The HRI signature consists of 11 HRDEGs, and we focused on the 5 key genes (RGS16, SNAI1, CDR2L, FRMD5, and FSTL3), which exhibited elevated expression levels in tumor tissues and are prognostic risk factors for CC. This evidence concerns the gene RGS16 and neoplasm.